Rothschild Investment LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.45K | Sell |
385
-20
| -5% | -$179 | ﹤0.01% | 1694 |
|
2025
Q1 | $3.04K | Buy |
405
+155
| +62% | +$1.16K | ﹤0.01% | 1667 |
|
2024
Q4 | $1.88K | Buy |
250
+65
| +35% | +$489 | ﹤0.01% | 1839 |
|
2024
Q3 | $1.41K | Buy |
185
+75
| +68% | +$570 | ﹤0.01% | 1923 |
|
2024
Q2 | $680 | Buy |
110
+85
| +340% | +$525 | ﹤0.01% | 1854 |
|
2024
Q1 | $127 | Buy |
+25
| New | +$127 | ﹤0.01% | 2051 |
|